v3.26.1
INVESTMENT IN AN ASSOCIATE (Tables)
 12 Months Ended
Dec. 31, 2025
Notes and other explanatory information [abstract]  
SCHEDULE OF INVESTMENT IN ASSOCIATE

The Group’s investment in the associate is summarized below:

 

   2024   2025 
   S$   S$ 
Beginning of financial year   195,073    220,950 
Share of post-acquisition profit/(losses)   13,765    (6,391)
Disposal   -    (223,204)
Currency realignment   12,112    8,645 
End of financial year   220,950    - 
SCHEDULE OF KEY ASSUMPTIONS OF INVESTMENT IN ASSOCIATE

Key assumptions used to determine the value in use of the investment in associate are as follows:

 

   2024 
   % 
Revenue growth rate   7.53 
Discount rate   13.90 

 

Name of entity  Principal activities  Country of business / incorporation  Group’s effective
equity interest held		 
         2024   2025 
         %   % 
Landmark Medical Centre Sdn Bhd  Operations of private specialist hospital  Malaysia   20    Nil 
SCHEDULE OF FINANCIAL INFORMATION INVESTMENT IN ASSOCIATE

The following table illustrates the summarized financial information of the Group’s material associate (and not the Group’s share of those amounts), adjusted for difference in accounting policies between the Group and the associate, if any.

 

   2024 
   S$ 
     
Current assets   558,877 
Non-current assets (including fair value of hospital license)   798,401 
Current liabilities   (75,061)
Non-current liabilities   (177,468)
Adjusted net assets of the associate   1,104,749 
      
Revenue   810,223 
Profit for the year   68,827 
SCHEDULE OF RECONCILIATION OF FINANCIAL INFORMATION IN INVESTMENT

Reconciliation of the summarized financial information presented to the carrying amount of the Group’s investment in the associate is as follows:

 

   2024 
   S$ 
Adjusted net assets   1,104,749 
      
Group’s equity interest   20%
Group share of net assets   220,950 
Carrying value   220,950